Skip to main content
. 2019 May 1;36(3):243–250. doi: 10.36141/svdld.v36i3.8219

Table 3.

Smoking status in different groups of PSV in comparison with control group

Variables Smokers (%) P*
PSV group
ANCA associated vasculitis 11 (30.6) 0.617
Large vessel vasculitis 7 (17.5)
Immune complex small vessel vasculitis and cutaneous LCV 4 (16.7)
Medium vessel vasculitis (PAN and others) 5 (20)
Control group 41 (19.5)

PSV: primary systemic vasculitides;

Data were displayed as numbers (percentages).

* P values indicate comparison between groups (Chi squared).